Long non-coding RNA: a new player in cancer

Hua Zhang1, Zhenhua Chen, Xinxin Wang

  • 1China-America Cancer Research Institute, Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College, Dongguan 523808, China.

Insights

Long non-coding RNAs (lncRNAs) are crucial in biological processes and cancer. This review explores novel lncRNAs

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cellular functions.
  • Dysregulation of lncRNAs is implicated in the development and progression of complex human diseases, particularly cancer.
  • While some lncRNA functions in cancer are known, many remain uncharacterized, hindering a full understanding of their regulatory mechanisms.

Purpose of the Study:

  • To review recent advancements in understanding lncRNA mechanisms and functions in cancer.
  • To highlight the oncogenic and tumor-suppressive roles of newly identified lncRNAs.
  • To discuss the potential involvement of these novel lncRNAs in cancer-related pathways and their utility as diagnostic and prognostic biomarkers.

Main Methods:

  • Literature review and synthesis of recent research findings on lncRNAs in cancer.
  • Focus on novel lncRNAs and their characterized functions.
  • Analysis of pathways and biomarker potential.

Main Results:

  • Emerging evidence points to significant roles for lncRNAs in cancer initiation and progression.
  • Newly identified lncRNAs exhibit both oncogenic and tumor-suppressive functions.
  • lncRNAs are involved in various cancer-associated molecular pathways.
  • Novel lncRNAs show promise as biomarkers for cancer diagnosis and prognosis.

Conclusions:

  • lncRNAs are critical regulators in cancer biology.
  • Further research into novel lncRNAs will elucidate complex cancer mechanisms.
  • lncRNAs hold significant potential for clinical applications in oncology, including diagnostics and prognostics.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...